165 related articles for article (PubMed ID: 9642077)
1. Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator.
Yang SQ; Craik CS
J Mol Biol; 1998 Jun; 279(4):1001-11. PubMed ID: 9642077
[TBL] [Abstract][Full Text] [Related]
2. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
[TBL] [Abstract][Full Text] [Related]
3. Ecotin: a serine protease inhibitor with two distinct and interacting binding sites.
Yang SQ; Wang CI; Gillmor SA; Fletterick RJ; Craik CS
J Mol Biol; 1998 Jun; 279(4):945-57. PubMed ID: 9642073
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin.
Wang CI; Yang Q; Craik CS
J Biol Chem; 1995 May; 270(20):12250-6. PubMed ID: 7744876
[TBL] [Abstract][Full Text] [Related]
5. The role of ecotin dimerization in protease inhibition.
Eggers CT; Wang SX; Fletterick RJ; Craik CS
J Mol Biol; 2001 May; 308(5):975-91. PubMed ID: 11352586
[TBL] [Abstract][Full Text] [Related]
6. Computer-assisted mutagenesis of ecotin to engineer its secondary binding site for urokinase inhibition.
Laboissière MC; Young MM; Pinho RG; Todd S; Fletterick RJ; Kuntz I; Craik CS
J Biol Chem; 2002 Jul; 277(29):26623-31. PubMed ID: 11959867
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix.
Perona JJ; Tsu CA; Craik CS; Fletterick RJ
Biochemistry; 1997 May; 36(18):5381-92. PubMed ID: 9154920
[TBL] [Abstract][Full Text] [Related]
8. Engineering of a macromolecular scaffold to develop specific protease inhibitors.
Stoop AA; Craik CS
Nat Biotechnol; 2003 Sep; 21(9):1063-8. PubMed ID: 12923547
[TBL] [Abstract][Full Text] [Related]
9. The contribution of key hydrophobic residues in ecotin to enzyme-inhibitor complex stability.
McCrudden MT; Ryan LA; Turkington P; Timson DJ
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1207-10. PubMed ID: 19912053
[TBL] [Abstract][Full Text] [Related]
10. Engineering ecotin for identifying proteins with a trypsin fold.
Sathler PC; Craik CS; Takeuchi T; Zingali RB; Castro HC
Appl Biochem Biotechnol; 2010 Apr; 160(8):2355-65. PubMed ID: 19728173
[TBL] [Abstract][Full Text] [Related]
11. A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue.
Andersen LM; Wind T; Hansen HD; Andreasen PA
Biochem J; 2008 Jun; 412(3):447-57. PubMed ID: 18318660
[TBL] [Abstract][Full Text] [Related]
12. The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase.
Eggers CT; Murray IA; Delmar VA; Day AG; Craik CS
Biochem J; 2004 Apr; 379(Pt 1):107-18. PubMed ID: 14705961
[TBL] [Abstract][Full Text] [Related]
13. Ecotin modulates thrombin activity through exosite-2 interactions.
Castro HC; Monteiro RQ; Assafim M; Loureiro NI; Craik C; Zingali RB
Int J Biochem Cell Biol; 2006; 38(11):1893-900. PubMed ID: 16843700
[TBL] [Abstract][Full Text] [Related]
14. Affinity purification of recombinant trypsinogen using immobilized ecotin.
Lengyel Z; Pál G; Sahin-Tóth M
Protein Expr Purif; 1998 Mar; 12(2):291-4. PubMed ID: 9518472
[TBL] [Abstract][Full Text] [Related]
15. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
16. Determining protein-protein interactions by oxidative cross-linking of a glycine-glycine-histidine fusion protein.
Brown KC; Yu Z; Burlingame AL; Craik CS
Biochemistry; 1998 Mar; 37(13):4397-406. PubMed ID: 9521759
[TBL] [Abstract][Full Text] [Related]
17. Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).
Katz BA; Luong C; Ho JD; Somoza JR; Gjerstad E; Tang J; Williams SR; Verner E; Mackman RL; Young WB; Sprengeler PA; Chan H; Mortara K; Janc JW; McGrath ME
J Mol Biol; 2004 Nov; 344(2):527-47. PubMed ID: 15522303
[TBL] [Abstract][Full Text] [Related]
18. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
[TBL] [Abstract][Full Text] [Related]
20. The extended interactions and Gla domain of blood coagulation factor Xa.
Wang SX; Hur E; Sousa CA; Brinen L; Slivka EJ; Fletterick RJ
Biochemistry; 2003 Jul; 42(26):7959-66. PubMed ID: 12834348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
